Lalarukh Malik, MD
Family Practice · Germantown, MDNPI 1740497601
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Novo Nordisk at 27.2% of the total. Reporting peaked in 2019 at $869 and has fallen 97.5% since, to $21 in 2024. Among family practice clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $24.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$426
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$343
- AstraZeneca$257
- Amgen$232
- Lilly USA, LLC$144
- Pfizer$76
- plus $89 from 2 others
What the payments were for
- Food & beverage$1,567100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 14 | $426 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 22 | $343 |
| AstraZeneca | 10 | $257 |
| Amgen | 4 | $232 |
| Lilly USA, LLC | 8 | $144 |
| Pfizer | 1 | $76 |
| Boehringer Ingelheim | 3 | $58 |
| Gilead | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,567 in reported general payments places this provider in the 95th percentile of 195 family practice providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ventolin HfaAlbuterol Sulfate | 11 | $745 |
| Nebivolol Hcl | 12 | $512 |
| Rosuvastatin Calcium | 36 | $505 |
| Amlodipine Besylate | 46 | $285 |
| Bumetanide | 14 | $219 |
| Levothyroxine Sodium | 18 | $180 |
| Fenofibric AcidFenofibric Acid (Choline) | 12 | $169 |
| Sertraline Hcl | 18 | $161 |
| Famotidine | 20 | $154 |
| Metformin Hcl ErMetformin Hcl | 14 | $148 |
| Pantoprazole Sodium | 14 | $146 |
| Lansoprazole | 11 | $102 |
| Hydralazine Hcl | 14 | $102 |
| Furosemide | 30 | $61 |
| Atorvastatin Calcium | 15 | $60 |
Paid to pharmacies, not to this prescriber.
Other family practice in Germantown
- Jenel WyattGermantown$0
- Ursula HeberleinGermantown$0
- Wei XuGaithersburg$7K
- Archana SoodBel Air$444
- Gino MendozaRockville$415
- Ibrahim SalihForestville$117
- Ivara EsegeBaltimore$18
- Nicholas BowerDundalk$0
- Angelica EhiobaMitchellville$0
- Rohit SeemRockville$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.